Immunohistochemical comparison of chromogranins A and B and secretogranin II with calcitonin and calcitonin gene-related peptide expression in normal, hyperplastic and neoplastic C-cells of the human thyroid
- PMID: 1356907
- DOI: 10.1111/j.1365-2559.1992.tb00380.x
Immunohistochemical comparison of chromogranins A and B and secretogranin II with calcitonin and calcitonin gene-related peptide expression in normal, hyperplastic and neoplastic C-cells of the human thyroid
Abstract
Normal and hyperplastic thyroid C-cells and 14 cases of medullary thyroid carcinoma were investigated immunohistochemically with antibodies against chromogranins A and B, secretogranin II, calcitonin and calcitonin gene-related peptide (CGRP). Normal and hyperplastic C-cells showed strong calcitonin and chromogranin A immunoreactivity whereas CGRP, chromogranin B and secretogranin II expression was less intense. Strong calcitonin and chromogranin A immunoreactivity was also found in the majority of tumour cells in medullary thyroid carcinoma. The CGRP, chromogranin B and secretogranin II staining observed was present in variable patterns. In some cases CGRP, chromogranin B and secretogranin II could only be demonstrated in isolated tumour cells with elongated processes suggestive of neuronal differentiation of these cells. The biological function(s) of the chromogranins/secretogranins remain(s) still unclear. There is evidence that these proteins are pro-peptides which give rise to functionally active compounds. Studies on normal C-cells and medullary thyroid carcinoma may elucidate the role of chromogranins/secretogranins in endocrine and neuronal cells.
Similar articles
-
Chromogranin A immunoreactivity compared with argyrophilia, calcitonin immunoreactivity, and amyloid as tumour markers in the histopathological diagnosis of medullary (C-cell) thyroid carcinoma.Pathol Res Pract. 1992 Feb;188(1-2):123-30. doi: 10.1016/s0344-0338(11)81167-2. Pathol Res Pract. 1992. PMID: 1594480
-
Calcitonin and calcitonin gene-related peptide mRNA detection in a population of hyperplastic parathyroid cells also expressing chromogranin B.Lab Invest. 1995 Jul;73(1):90-5. Lab Invest. 1995. PMID: 7603045
-
Chromogranin A and B and secretogranin II in medullary carcinomas of the thyroid.Am J Surg Pathol. 1987 Jul;11(7):551-6. doi: 10.1097/00000478-198707000-00007. Am J Surg Pathol. 1987. PMID: 3300386
-
[Medullary thyroid carcinoma. Immunohistochemical markers in histopathology and research].Zentralbl Pathol. 1993 Jun;139(2):115-29. Zentralbl Pathol. 1993. PMID: 8369268 Review. German.
-
Distribution of C cells in the normal and diseased thyroid gland.Pathol Annu. 1993;28 Pt 1:205-29. Pathol Annu. 1993. PMID: 8416138 Review. No abstract available.
Cited by
-
The Pathology of Medullary Carcinoma of the Thyroid: Review of the Literature and Personal Experience on 62 Cases.Endocr Pathol. 1996 Spring;7(1):1-20. doi: 10.1007/BF02739911. Endocr Pathol. 1996. PMID: 12114676
-
Isthmus-preserving total bilobectomy: an adequate operation for C-cell hyperplasia.World J Surg. 2006 May;30(5):860-71. doi: 10.1007/s00268-005-0424-z. World J Surg. 2006. PMID: 16680601
-
Immunohistochemical detection of secretoneurin, a novel neuropeptide endoproteolytically processed from secretogranin II, in normal human endocrine and neuronal tissues.Histochem J. 1995 Jun;27(6):473-81. Histochem J. 1995. PMID: 7558897
-
The granin protein family: markers for neuroendocrine cells and tools for the diagnosis of neuroendocrine tumors.J Endocrinol Invest. 1994 Mar;17(3):207-25. doi: 10.1007/BF03347721. J Endocrinol Invest. 1994. PMID: 8051343 Review. No abstract available.
-
Secretogranin IV immunoreactivity in medullary thyroid carcinoma: an immunohistochemical study of 62 cases.Virchows Arch A Pathol Anat Histopathol. 1993;423(2):85-9. doi: 10.1007/BF01606581. Virchows Arch A Pathol Anat Histopathol. 1993. PMID: 7692664
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials